New Jersey Statutes 26:2-111.7. “Let Them Be Little Act,” screening of newborns for MPSI and MPSII provided
Terms Used In New Jersey Statutes 26:2-111.7
- Evidence: Information presented in testimony or in documents that is used to persuade the fact finder (judge or jury) to decide the case for one side or the other.
- State: extends to and includes any State, territory or possession of the United States, the District of Columbia and the Canal Zone. See New Jersey Statutes 1:1-2
(1) the development of a reliable test or series of tests for screening newborns for MPS I using dried blood spots and quality assurance testing methodology for Hunter syndrome testing;
(2) the availability of quality assurance materials for the MPS I test from the federal Centers for Disease Control and Prevention;
(3) the inclusion of newborn screening for MPS I in the Recommended Uniform Screening Panel of the United States Secretary of Health and Human Services’ Advisory Committee on Heritable Disorders in Newborns and Children, after the committee’s evidence review of newborn screening for MPS I;
(4) the review by the Department of Health of the proposed test; and
(5) the acquisition of equipment necessary to implement the expanded screening tests by the State’s Newborn Screening Laboratory.
b. All infants born in this State shall be tested for mucopolysaccharidosis II (MPS II), also called Hunter syndrome, beginning six months following the occurrence of all of the following:
(1) the development of a reliable test or series of tests for screening newborns for MPS II using dried blood spots and quality assurance testing methodology for Hunter syndrome testing;
(2) the availability of quality assurance materials for the MPS II test from the federal Centers for Disease Control and Prevention;
(3) the inclusion of newborn screening for MPS II in the Recommended Uniform Screening Panel of the United States Secretary of Health and Human Services’ Advisory Committee on Heritable Disorders in Newborns and Children, after the committee’s evidence review of newborn screening for MPS II;
(4) the review by the Department of Health of the proposed test; and
(5) the acquisition of equipment necessary to implement the expanded screening tests by the State’s Newborn Screening Laboratory.
c. The Department of Health may charge a reasonable fee and any reasonable increase in this fee as necessary, for the tests performed pursuant to this section. The amount of the fee and the procedures for collecting the fee shall be determined by the Commissioner of Health.
L.2014, c.44, s.1.